Drug advertising for presentation

Post on 02-Nov-2014

1.169 views 0 download

description

A view of drug advertising, including benefits and problems with this growing field.

Transcript of Drug advertising for presentation

Drug Advertising

The pros, cons and caveats

Introduction

How bad has it become?

• Youtube Act 1

• Youtube Act 2

YearSpending on DTC

advertising

Spending onpromotion to physicians

Retail value of samples

R & D

1997 $1.1 $3.9 $6.0 $15.5

2000 $2.5 $5.6 $8.5 $21.4

2003 $3.3 $7.4 $13.5 $27.1

2004 $4.0 $7.8 $15.9 $29.8

2005 $4.2 $7.2 not available $31.4

Avg annual % increase

19.6 9.0 14.9 9.3

Total % increase, ‘97-’05

296.4 86.0 162.4 103.3

Spending on drug advertising from 1997 - 2005

Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising', GAO report Number GAO-07-54, December 14, 2006

Incentives for refills

http://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm

Patient & caregiver tools

http://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm

Pros for consumer

• Educates patients• Prompts patients to visit doctor• Prompts patients to talk about difficult

conditions• Can reduce costs by early treatment• Might alert patients to a potential

disease• Empowers consumers to be active in

their care

Pros for doctor

• Facilitates communication with patients

• Prompts patients to discuss conditions openly

• Promotes need for MDs to remain educated about drugs

• Strengthens provider-patient bond

Pros for drug companies

• Drug companies feel patients have right to know and choose

• They empower consumers with information

• They urge patients to seek treatment

• Can reduce spending on medical services through early treatment and diagnosis

Cons of drug advertising

• Appeals to emotions

• Misleading

• Benefits overstated

• Understated risks & side effects

• Influences patients to ask for meds they don’t need

• Encourages money on brand names

More cons…

• Sometimes they target a condition that is not a condition (like the spoofs)

• Undermines physician/patient relationship

• Bribery from drug companies

• Consumers lack information on safety & efficacy needed to make a smart decision

• FDA oversight is weak

http://democracyinaction.org/dia/organizations/commercialalert/campaign.jsp?campaign_KEY=1415&t=stop_drug_ads_home.dwt